Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to Atherosclerosis

PHASE3RecruitingINTERVENTIONAL
Enrollment

2,800

Participants

Timeline

Start Date

May 17, 2023

Primary Completion Date

September 1, 2027

Study Completion Date

September 1, 2027

Conditions
StrokeStroke, IschemicAtherosclerosisMyocardial InfarctionCoronary SyndromeTIACardiac DiseaseCerebral Infarction
Interventions
DRUG

Colchicine 0.5 MG

Colchicine is a medication used to treat gout and Behçet's disease. In gout, it is less preferred to NSAIDs or steroids. Other uses for colchicine include the management of pericarditis and familial Mediterranean fever.

DRUG

Ticagrelor 90mg

Ticagrelor, sold under the brand name Brilinta among others, is a medication used for the prevention of stroke, heart attack and other events in people with acute coronary syndrome, meaning problems with blood supply in the coronary arteries. It acts as a platelet aggregation inhibitor by antagonising the P2Y 12 receptor.

DRUG

Aspirin 75-300mg

Also known as Aspirin, acetylsalicylic acid (ASA) is a commonly used drug for the treatment of pain and fever due to various causes. Acetylsalicylic acid has both anti-inflammatory and antipyretic effects. This drug also inhibits platelet aggregation and is used in the prevention of blood clots stroke, and myocardial infarction (MI).

Trial Locations (1)

75010

RECRUITING

URC Lariboisière-Fernand Widal-Saint Louis, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER